Search Results

There are 22672 results for: content related to: Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  3. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  4. Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection

    Hepatology Research

    Naoki Morishita, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Yuki Tahata, Ryoko Yamada, Takayuki Yakushijin, Atsushi Hosui, Sadaharu Iio, Akira Yamada, Hideki Hagiwara, Eiji Mita, Yukinori Yamada, Toshifumi Ito, Masami Inada, Kazuhiro Katayama, Iwao Yabuuchi, Yasuharu Imai, Hayato Hikita, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 26 OCT 2016, DOI: 10.1111/hepr.12817

  5. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 691–701, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Yuya Seko, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Rie Mineta, Sachiyo Watahiki, Mariko Kobayashi, Yoshiyuki Nakayasu, Hidetaka Tsuda, Keiji Aoki, Ichimaro Yamada and Hiromitsu Kumada

    Version of Record online : 29 NOV 2012, DOI: 10.1111/hepr.12009

  6. The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 3, March 2015, Pages: 254–262, T. Oze, N. Hiramatsu, T. Yakushijin, R. Yamada, N. Harada, N. Morishita, M. Oshita, E. Mita, T. Ito, Y. Inui, M. Inada, S. Tamura, H. Yoshihara, Y. Imai, M. Kato, T. Miyagi, Y. Yoshida, T. Tatsumi, A. Kasahara, N. Hayashi and T. Takehara

    Version of Record online : 31 JUL 2014, DOI: 10.1111/jvh.12289

  7. You have full text access to this OnlineOpen article
    Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 21, Issue 5, May 2014, Pages: 341–347, Y. Karino, I. Ozeki, S. Hige, M. Kimura, T. Arakawa, T. Nakajima, Y. Kuwata, T. Sato, T. Ohmura and J. Toyota

    Version of Record online : 25 AUG 2013, DOI: 10.1111/jvh.12162

  8. Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1165–1171, Kazuto Fukuda, Yasuharu Imai, Naoki Hiramatsu, Keiko Irishio, Takumi Igura, Yoshiyuki Sawai, Sachiyo Kogita, Yuki Makino, Rui Mizumoto, Yasushi Matsumoto, Masanori Nakahara, Sinichiro Zushi, Nobuyuki Kajiwara, Tsugiko Oze, Sumio Kawata, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12229

  9. Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy

    Liver International

    Volume 34, Issue 7, August 2014, Pages: 1018–1024, James F. Crismale, Valérie Martel-Laferrière, Kian Bichoupan, Emily Schonfeld, Alexis Pappas, Christina Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano, Ponni V. Perumalswami, Meena Bansal, Douglas T. Dieterich and Andrea D. Branch

    Version of Record online : 25 OCT 2013, DOI: 10.1111/liv.12342

  10. Efficacy and safety of telaprevir with pegylated interferon α-2a and ribavirin in Japanese patients

    Hepatology Research

    Hiromitsu Kumada, Fumitaka Suzuki, Naohiro Kamiya, Madori Orihashi, Yoshiyuki Nakayasu and Ichimaro Yamada

    Version of Record online : 4 JUN 2016, DOI: 10.1111/hepr.12722

  11. Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan

    Hepatology Research

    Volume 45, Issue 13, December 2015, Pages: 1267–1275, Muneshige Shiraishi, Itsuro Umebayashi, Hiroaki Matsuda, Keisuke Sawamura, Aiko Okada, Masako Karino and Yoshihide Nogami

    Version of Record online : 4 MAR 2015, DOI: 10.1111/hepr.12502

  12. You have free access to this content
    An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1433–1444, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 26 SEP 2011, DOI: 10.1002/hep.24641

  13. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  14. You have free access to this content
    Telaprevir versus simeprevir for the treatment of recurrent hepatitis C after living donor liver transplantation

    Hepatology Research

    Volume 46, Issue 3, March 2016, Pages: E136–E145, Toru Ikegami, Tomoharu Yoshizumi, Yoshihro Yoshida, Takeshi Kurihara, Norifumi Harimoto, Shinji Itoh, Masahiro Shimokawa, Takasuke Fukuhara, Ken Shirabe and Yoshihiko Maehara

    Version of Record online : 6 JUL 2015, DOI: 10.1111/hepr.12546

  15. You have free access to this content
    Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E397–E407, Hiroki Nishikawa, Hirayuki Enomoto, Akihiro Nasu, Nobuhiro Aizawa, Masaki Saito, Akihiro Tamori, Norifumi Kawada, Toru Kimura, Yukio Osaki and Shuhei Nishiguchi

    Version of Record online : 6 MAY 2014, DOI: 10.1111/hepr.12326

  16. You have free access to this content
    Viral Hepatitis

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 151–177,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_14

  17. You have free access to this content
    Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy

    Liver Transplantation

    Volume 20, Issue 9, September 2014, Pages: 1106–1117, Katja Roos, Daniel Gotthardt, Thomas Giese, Paul Schnitzler, Wolfgang Stremmel, David Czock and Christoph Eisenbach

    Version of Record online : 4 AUG 2014, DOI: 10.1002/lt.23925

  18. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2090–2099, Patrick Miailhes, Camille Gilbert, Karine Lacombe, Joop E. Arends, Massimo Puoti, Jürgen K. Rockstroh, Philippe Sogni, Hélène Fontaine, Eric Rosenthal, Maria Winnock, Marc-Arthur Loko, Linda Wittkop, François Dabis, Dominique Salmon and the ESCMID European Study Group on Viral Hepatitis

    Version of Record online : 23 FEB 2015, DOI: 10.1111/liv.12799

  19. You have free access to this content
    Viral Hepatitis and Transplant

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1042A–1054A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26877

  20. Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

    The Journal of Clinical Pharmacology

    Volume 55, Issue 10, October 2015, Pages: 1147–1156, Sivi Ouwerkerk-Mahadevan, Atef Halabi, Blanka Cieslarová, Indra Aerts, James Witek, Rodica Van Solingen-Ristea and Donghan Luo

    Version of Record online : 7 JUL 2015, DOI: 10.1002/jcph.545